Rxo Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | -$0.0900 |
| EPS actual | -$0.0900 |
| Revenue estimate | 1.342B |
| Revenue actual | 1.425B |
| Revenue Surprise | 6.18% |
| Release date | Feb 06, 2026 |
| EPS estimate | -$0.0400 |
| EPS actual | -$0.0700 |
| EPS Surprise | -75.00% |
| Revenue estimate | 1.49B |
| Revenue actual | 1.469B |
| Revenue Surprise | -1.42% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0100 |
| EPS Surprise | -66.67% |
| Revenue estimate | 1.515B |
| Revenue actual | 1.421B |
| Revenue Surprise | -6.21% |
| Release date | Aug 07, 2025 |
| EPS estimate | $0.0200 |
| EPS actual | $0.0400 |
| EPS Surprise | 100.00% |
| Revenue estimate | 1.447B |
| Revenue actual | 1.419B |
| Revenue Surprise | -1.96% |
Last 4 Quarters for Rxo
Below you can see how RXO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 07, 2025 |
| Price on release | $14.78 |
| EPS estimate | $0.0200 |
| EPS actual | $0.0400 |
| EPS surprise | 100.00% |
| Date | Price |
|---|---|
| Aug 01, 2025 | $15.00 |
| Aug 04, 2025 | $15.28 |
| Aug 05, 2025 | $15.48 |
| Aug 06, 2025 | $15.44 |
| Aug 07, 2025 | $14.78 |
| Aug 08, 2025 | $14.57 |
| Aug 11, 2025 | $14.25 |
| Aug 12, 2025 | $15.12 |
| Aug 13, 2025 | $15.55 |
| 4 days before | -1.47% |
| 4 days after | 5.21% |
| On release day | -1.42% |
| Change in period | 3.67% |
| Release date | Nov 06, 2025 |
| Price on release | $13.55 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0100 |
| EPS surprise | -66.67% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $17.73 |
| Nov 03, 2025 | $17.62 |
| Nov 04, 2025 | $17.38 |
| Nov 05, 2025 | $17.62 |
| Nov 06, 2025 | $13.55 |
| Nov 07, 2025 | $12.49 |
| Nov 10, 2025 | $11.51 |
| Nov 11, 2025 | $12.18 |
| Nov 12, 2025 | $12.36 |
| 4 days before | -23.58% |
| 4 days after | -8.78% |
| On release day | -7.82% |
| Change in period | -30.29% |
| Release date | Feb 06, 2026 |
| Price on release | $16.90 |
| EPS estimate | -$0.0400 |
| EPS actual | -$0.0700 |
| EPS surprise | -75.00% |
| Date | Price |
|---|---|
| Feb 02, 2026 | $15.49 |
| Feb 03, 2026 | $15.94 |
| Feb 04, 2026 | $17.07 |
| Feb 05, 2026 | $16.58 |
| Feb 06, 2026 | $16.90 |
| Feb 09, 2026 | $16.05 |
| Feb 10, 2026 | $16.39 |
| Feb 11, 2026 | $16.33 |
| Feb 12, 2026 | $12.99 |
| 4 days before | 9.10% |
| 4 days after | -23.14% |
| On release day | -5.03% |
| Change in period | -16.14% |
| Release date | May 07, 2026 |
| Price on release | $23.15 |
| EPS estimate | -$0.0900 |
| EPS actual | -$0.0900 |
| Date | Price |
|---|---|
| May 01, 2026 | $19.59 |
| May 04, 2026 | $17.70 |
| May 05, 2026 | $18.19 |
| May 06, 2026 | $19.62 |
| May 07, 2026 | $23.15 |
| May 08, 2026 | $21.75 |
| May 11, 2026 | $20.70 |
| May 12, 2026 | $20.05 |
| May 13, 2026 | $19.81 |
| 4 days before | 18.17% |
| 4 days after | -14.43% |
| On release day | -6.05% |
| Change in period | 1.12% |
Rxo Earnings Call Transcript Summary of Q1 2026
RXO reported Q1 2026 revenue of $1.4 billion, gross margin of 14.2% and adjusted EBITDA of $6 million (impacted by severe weather and a $3M hit to last‑mile). Management says the freight recovery is supply‑driven (capacity exiting the market due to regulatory enforcement), which is tightening truckload capacity and supporting rapidly rising rates. Key operational trends: brokerage full truckload volume improved every month in Q1, spot mix increased meaningfully (spot share rose ~500 bps sequentially and ~600 bps year‑over‑year, reaching ~35% of truckload in April) and gross profit per load rose sequentially. RXO upgraded its contract rate outlook: management now expects full‑year 2026 contract rates to increase by high single digits (vs. prior low‑to‑mid single digits). Managed Transportation won >$100M of freight under management in Q1 and has a growing pipeline; the new Middle Mile solution launched in February and already has a >$70M pipeline with ~$20M in wins. Technology/AI (Agentic AI, spot quote agent, matching algorithms, fraud protection) is being rolled out and early adopters are seeing higher volume and gross profit per load; Agentic tools automated >500,000 calls in Q1. Capital and cash: liquidity $386M at quarter end, net leverage ~3.7x LTM bank adjusted EBITDA, negative adjusted free cash flow of $15M in Q1 (timing and higher H1 CapEx), and a completed refinancing of 2027 senior notes (2031 maturity). Guidance: Q2 adjusted EBITDA of $27M–$37M (management sees significant sequential improvement and a path to the high end), expects brokerage volume roughly flat y/y in Q2 and truckload to resume outperformance vs. market by mid‑year. Management reiterated mid‑cycle EBITDA margin expectations (mid‑single digits) with higher peak potential and said AI and scale should drive structural margin improvement over time.
Sign In
Buy RXO